- Home
- SOS vs APRE Comparison
SOS vs APRE Comparison
Compare SOS & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOS
- APRE
- Stock Information
- Founded
- SOS 2004
- APRE 2006
- Country
- SOS China
- APRE United States
- Employees
- SOS N/A
- APRE N/A
- Industry
- SOS Finance: Consumer Services
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOS Finance
- APRE Health Care
- Exchange
- SOS Nasdaq
- APRE Nasdaq
- Market Cap
- SOS 10.7M
- APRE 9.4M
- IPO Year
- SOS 2017
- APRE 2019
- Fundamental
- Price
- SOS $2.00
- APRE $1.50
- Analyst Decision
- SOS
- APRE Strong Buy
- Analyst Count
- SOS 0
- APRE 1
- Target Price
- SOS N/A
- APRE $20.00
- AVG Volume (30 Days)
- SOS 1.1M
- APRE 33.7K
- Earning Date
- SOS 09-24-2025
- APRE 11-06-2025
- Dividend Yield
- SOS N/A
- APRE N/A
- EPS Growth
- SOS N/A
- APRE N/A
- EPS
- SOS N/A
- APRE N/A
- Revenue
- SOS $231,424,000.00
- APRE $841,012.00
- Revenue This Year
- SOS N/A
- APRE N/A
- Revenue Next Year
- SOS N/A
- APRE N/A
- P/E Ratio
- SOS N/A
- APRE N/A
- Revenue Growth
- SOS 150.42
- APRE N/A
- 52 Week Low
- SOS $1.18
- APRE $1.41
- 52 Week High
- SOS $2.04
- APRE $5.01
- Technical
- Relative Strength Index (RSI)
- SOS 40.87
- APRE 41.55
- Support Level
- SOS $1.50
- APRE $1.44
- Resistance Level
- SOS $1.95
- APRE $1.66
- Average True Range (ATR)
- SOS 0.30
- APRE 0.08
- MACD
- SOS 0.17
- APRE -0.00
- Stochastic Oscillator
- SOS 64.71
- APRE 26.67
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.